Basal brain oxidative and nitrative stress levels are finely regulated by the interplay between superoxide dismutase 2 and p53
MetadataShow full item record
Di Domenico F.
St Clair D.K.
Superoxide dismutases (SODs) are the primary reactive oxygen species (ROS)-scavenging enzymes of the cell and catalyze the dismutation of superoxide radicals O2- to H2O2 and molecular oxygen (O2). Among the three forms of SOD identified, manganese-containing SOD (MnSOD, SOD2) is a homotetramer located wholly in the mitochondrial matrix. Because of the SOD2 strategic location, it represents the first mechanism of defense against the augmentation of ROS/reactive nitrogen species levels in the mitochondria for preventing further damage. This study seeks to understand the effects that the partial lack (SOD2-/+) or the overexpression (TgSOD2) of MnSOD produces on oxidative/nitrative stress basal levels in different brain isolated cellular fractions (i.e., mitochondrial, nuclear, cytosolic) as well as in the whole-brain homogenate. Furthermore, because of the known interaction between SOD2 and p53 protein, this study seeks to clarify the impact that the double mutation has on oxidative/nitrative stress levels in the brain of mice carrying the double mutation (p53-/- × SOD2-/+ and p53-/- × TgSOD2). We show that each mutation affects mitochondrial, nuclear, and cytosolic oxidative/nitrative stress basal levels differently, but, overall, no change or reduction of oxidative/nitrative stress levels was found in the whole-brain homogenate. The analysis of well-known antioxidant systems such as thioredoxin-1 and Nrf2/HO-1/BVR-A suggests their potential role in the maintenance of the cellular redox homeostasis in the presence of changes of SOD2 and/or p53 protein levels. © 2015 Wiley Periodicals, Inc.
Showing items related by title, author, creator and subject.
Portacaval shunting causes differential mitochondrial superoxide production in brain regions (2020) Kosenko E.A.; Tikhonova L.A.; Alilova G.A.; Montoliu C.; Barreto G.E.; Aliev G.; Kaminsky Y.G. (Elsevier Inc., 2017)
Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm (2020) Barone E.; Di Domenico F.; Cassano T.; Arena A.; Tramutola A.; Lavecchia M.A.; Coccia R.; Butterfield D.A.; Perluigi M. (Elsevier Inc., 2016)
ReviewBarone E.; Arena A.; Head E.; Butterfield D.A.; Perluigi M. (Elsevier Inc., 2018)